首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1392015

鼻減充血劑市場：按產品類型、按減充血劑類型、按作用機制、按應用、按配銷通路、按地區

Decongestant Market, By Product Type, By Type of Decongestant (Oral Decongestants, Nasal Decongestants ), By Mode of Action, By Application, By Distribution Channel, By Geography

出版日期: 2023年11月10日 | 出版商:

Coherent Market Insights | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球鼻減充血劑市場規模預計將從 2023 年的 157.3 億美元增至 2030 年的 246.7 億美元，預測期內年複合成長率為 6.6%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	157.3億美元
實績資料	2018-2021	預測期	2023-2030
預測期年複合成長率	6.60%	2030年市場規模預測	246.7億美元

圖 1. 2023 年鼻減充血劑的全球市場佔有率(%)，依地區分類

鼻減充血劑是透過收縮鼻道血管來緩解鼻充血的藥物。透過收縮鼻黏膜血管，鼻竇排放並減少腫脹。常見的鼻減充血劑包括偽麻黃鹼和去氧腎上腺素。它們可以快速暫時緩解症狀，用於治療感冒、鼻竇、花粉症、過敏等。但不建議長期使用，因為藥效過後鼻塞可能會復發。長期緩解包括生理食鹽水鼻腔清洗、類固醇滴鼻劑和抗組織胺。過度使用或長期使用，尤其是鼻減充血噴霧劑，可能會導致反彈性充血，即停藥後鼻道變得更加充盈。

市場動態：

全球鼻減充血劑市場正穩定成長，主要受到世界過敏盛行率上升的影響。主要的市場促進因素包括由於環境條件變化和都市區空氣污染導致季節性過敏性疾病迅速增加。此外，患者越來越意識到透過滴鼻劑和膠囊等便利的給藥方式可以有效緩解鼻塞症狀，這也推動了產品的採用。例如，大公司正在推出其產品的學名藥，以滿足更廣泛的患者群體。另一方面，成藥處方鼻腔減充血藥的可用性和可負擔性正在增加市場收益。然而，關於定期使用超過 3 天的嚴格規定以及長期使用相關的副作用預計將阻礙市場成長。此外，到 2028 年之前，對皮質類固醇和免疫療法等替代治療方法的偏好也可能在一定程度上限制行業盈利。也就是說，旨在開發副作用較少的新配方的主要研發活動正在進行中，這可能會在預測期內為主要參與者提供有利的商機。

本研究的主要特點

該報告對全球鼻充血減充血劑市場進行了詳細分析，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和年複合成長率（CAGR%）。
它還闡明了各個細分市場的潛在商機，並解釋了該市場有吸引力的投資提案矩陣。
它還提供了有關市場促進因素、抑制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、業績和策略等參數，介紹了全球鼻減充血劑市場的主要企業。
該報告的見解將幫助行銷人員和經營團隊就未來的產品發布、類型升級、市場擴張和行銷策略負責人資訊的決策。
本研究報告針對該產業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
相關人員可以透過用於分析全球鼻減充血劑市場的各種策略矩陣來促進他們的決策。

Johnson & Johnson
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi SA
Bayer AG
Reckitt Benckiser Group plc
Prestige Consumer Healthcare Inc.
Procter & Gamble Co.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd..
Perrigo Company plc
Church & Dwight Co., Inc.
Church & Dwight Co., Inc.
Mylan NV
Marinomed Biotech AG
Reddy's Laboratories Ltd

第12章章節

調查方法
關於出版商

簡介目錄

Product Code: CMI5805

The global decongestant market size is expected to reach US$ 24.67 billion by 2030, from US$ 15.73 billion in 2023, at a CAGR of 6.6% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 15.73 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.60%	2030 Value Projection:	US$ 24.67 Bn

Figure 1. Global Decongestant Market Share (%), By Region, 2023

Decongestants are medications that help relieve nasal congestion by shrinking blood vessels in the nasal passages. They work by constricting the blood vessels in the nasal mucosa, which helps promote the drainage of sinus cavities and reduce swelling. Common decongestants include pseudoephedrine and phenylephrine. They provide rapid, temporary relief and are used to treat conditions like the common cold, sinusitis, hay fever, and allergies. However, prolonged use is not recommended, as rebound congestion may occur once the medication wears off. Alternative options for long-term relief include nasal saline rinses, steroid nasal sprays, and antihistamines. Overuse or prolonged use of nasal decongestant sprays, in particular, can lead to rebound congestion, where the nasal passages become more congested after the medication is discontinued.

Market Dynamics:

The global decongestant market is growing at a steady pace mainly influenced by rising prevalence of allergies worldwide. Some of the key market drivers include rapidly growing rate of seasonal allergy disorders fueled by changing environmental conditions and polluted urban atmospheres. Additionally, increasing patient awareness about effective symptomatic relief of nasal congestion through convenient delivery methods like nasal sprays and capsules is propelling the product adoption. For instance, major companies are launching generic copy products to cater wider patient segments. On the other hand, over-the-counter availability of several generic decongestants ensures easy accessibility and affordability augmenting market revenues. However, stringent regulations pertaining to regular consumption beyond 3 days along with adverse side effects associated with long term use are expected to hamper the market growth. Moreover, preference towards alternative treatment options like corticosteroids and immunotherapy may also limit the industry profitability to some extent through 2028. Nevertheless, ongoing R&D activities aimed at development of novel formulations with fewer side effects will likely create lucrative opportunities for key players over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global decongestant market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global decongestant market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Sanofi S.A., Bayer AG, Reckitt Benckiser Group plc, Prestige Consumer Healthcare Inc., Procter & Gamble Co., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, Perrigo Company plc, Church & Dwight Co., Inc., Mylan N.V. Marinomed Biotech AG, Dr. Reddy's Laboratories Ltd
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global decongestant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global decongestant market

Detailed Segmentation:

By Product Type:
- Tablets
- Capsules
- Nasal Sprays
- Others
By Type of Decongestant:
- Oral Decongestants:
- Pseudoephedrine
- Phenylephrine
- Others
- Nasal Decongestants:
- Oxymetazoline
- Xylometazoline
- Phenylephrine
- Naphazoline
- Others
By Mode of Action:
- Alpha-Adrenergic Agonists
- Vasoconstrictors
- Others
By Application:
- Seasonal Allergic Rhinitis
- Perennial Allergic Rhinitis
- Sinusitis
- Nasal Congestion
- Cold and Flu
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Hyper Market/Super Market
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profile:
- Johnson & Johnson
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Sanofi S.A.
- Bayer AG
- Reckitt Benckiser Group plc
- Prestige Consumer Healthcare Inc.
- Procter & Gamble Co.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Perrigo Company plc
- Church & Dwight Co., Inc.
- Mylan N.V.
- Marinomed Biotech AG
- Reddy's Laboratories Ltd

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet , By Product Type
- Market Snippet , By Type of Decongestant
- Market Snippet , By Mode of Action
- Market Snippet , By Application
- Market Snippet , By Distribution Channel
- Market Snippet , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Prevalence of Respiratory Conditions
- Side Effects of Decongestants
- Adoption of combination drug formulations
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
Pipeline Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Decongestant Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Decongestant Market, By Product Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Nasal Sprays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Decongestant Market, By Type of Decongestant, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Oral Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Pseudoephedrine
Phenylephrine
Others
Nasal Decongestants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Oxymetazoline
Xylometazoline
Phenylephrine
Naphazoline
Others

7. Global Decongestant Market, By Mode of Action, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Alpha-Adrenergic Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Vasoconstrictors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Decongestant Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Seasonal Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Perennial Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Sinusitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Nasal Congestion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Cold and Flu
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

9. Global Decongestant Market, By Distribution Channel, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Hyper Market/Super Market
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

10. Global Decongestant Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Country 2019-2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
U.S.
Canada
Lain America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018-2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type of Decongestant, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Mode of Action, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2018 - 2030, (US$ Bn)
North Africa
Central Africa
South Africa

11. Competitive Landscape

Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
GlaxoSmithKline plc
Novartis AG
Sanofi S.A.
Bayer AG
Reckitt Benckiser Group plc
Prestige Consumer Healthcare Inc.
Procter & Gamble Co.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd..
Perrigo Company plc
Church & Dwight Co., Inc.
Church & Dwight Co., Inc.
Mylan N.V.
Marinomed Biotech AG
Reddy's Laboratories Ltd
Analyst Views